Eli Lilly and Company annual shares outstanding for fiscal TTM was 896 million shares, a decrease of 0.2% from 898 million shares in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Shares Outstanding (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (M) | 896M | 898M | 904M | 903M | 950M | 954M | 957M | 958M | 1,034M | 1,052M | 1,101M | 1,105M | 1,111M | 1,117M | 1,146M | 1,114M | 1,106M | 1,098M | 1,094M | 1,091M | 1,087M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Shares Outstanding (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (M) | 896M | 898M | 899M | 900M | 901M | 903M | 905M | 904M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More LLY metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow
All LLY financial statements → Interactive LLY charts →
About TickerBase · Data methodology & sources